Should You Buy This Blue-Chip Dividend Stock Before November 1?

Operationally, results are solid. Net sales were $3.3 billion, up 3% year-over-year (YoY), with 2% organic growth driven by 4% higher volume offset by 2% lower price, showing demand is improving even as pricing remains a headwind. Strength was led by electronics and healthcare, aligning with where the portfolio is headed post-spinoff.For income-focused holders, the dividend case is straightforward. The yield stands at 2.06% with a 35.33% payout ratio, and the company has raised its dividend for four straigh ...